- Home
- CALC vs NDLS Comparison
CALC vs NDLS Comparison
Compare CALC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- NDLS
- Stock Information
- Founded
- CALC 2011
- NDLS 1995
- Country
- CALC United States
- NDLS United States
- Employees
- CALC N/A
- NDLS N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- CALC Health Care
- NDLS Consumer Discretionary
- Exchange
- CALC Nasdaq
- NDLS Nasdaq
- Market Cap
- CALC 20.9M
- NDLS 45.2M
- IPO Year
- CALC N/A
- NDLS 2013
- Fundamental
- Price
- CALC $2.01
- NDLS $0.86
- Analyst Decision
- CALC Strong Buy
- NDLS Strong Buy
- Analyst Count
- CALC 3
- NDLS 2
- Target Price
- CALC $16.33
- NDLS $3.00
- AVG Volume (30 Days)
- CALC 28.4K
- NDLS 93.9K
- Earning Date
- CALC 05-20-2025
- NDLS 05-07-2025
- Dividend Yield
- CALC N/A
- NDLS N/A
- EPS Growth
- CALC N/A
- NDLS N/A
- EPS
- CALC N/A
- NDLS N/A
- Revenue
- CALC N/A
- NDLS $495,670,000.00
- Revenue This Year
- CALC N/A
- NDLS $4.57
- Revenue Next Year
- CALC N/A
- NDLS $1.29
- P/E Ratio
- CALC N/A
- NDLS N/A
- Revenue Growth
- CALC N/A
- NDLS N/A
- 52 Week Low
- CALC $1.43
- NDLS $0.55
- 52 Week High
- CALC $6.02
- NDLS $2.36
- Technical
- Relative Strength Index (RSI)
- CALC 64.27
- NDLS 37.64
- Support Level
- CALC $1.94
- NDLS $0.81
- Resistance Level
- CALC $2.15
- NDLS $1.09
- Average True Range (ATR)
- CALC 0.13
- NDLS 0.08
- MACD
- CALC 0.07
- NDLS -0.00
- Stochastic Oscillator
- CALC 80.44
- NDLS 18.96
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.